Aytu BioPharma (AYTU) Earnings (2010 - 2026)
Aytu BioPharma (AYTU) earnings from Nov 30, 2010 to Mar 31, 2026. The TTM Aytu BioPharma (AYTU) earnings is -$34M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Aytu BioPharma (AYTU) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +32.64% |
| 5 Years TTM | -4.31% |
| 10 Years TTM | +10.21% |
| All Time TTM | +46.71% |
Annual Earnings change of Aytu BioPharma (AYTU)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$5.62M | -58.55% |
| 2025 | -$14M | -14.39% |
| 2024 | -$16M | -7.10% |
| 2023 | -$17M | -84.33% |
| 2022 | -$109M | +86.62% |
| 2021 | -$58M | +327.97% |
| 2020 | -$14M | -49.80% |
| 2019 | -$27M | +166.24% |
| 2018 | -$10M | -54.73% |
| 2017 | -$23M | -20.12% |
| 2016 | -$28M | +265.03% |
| 2015 | -$7.72M | +99.48% |
| 2014 | -$3.87M | +6350.00% |
| 2013 | -$60K | N/A |
| 2012 | -$60K | -57.14% |
| 2011 | -$140K | +133.33% |
| 2010 | -$60K | N/A |
| 2009 | -$60K | N/A |
| 2008 | -$60K | +20.00% |
| 2007 | -$50K | -28.57% |
| 2006 | -$70K | N/A |
Comparison Aytu BioPharma (AYTU) five years earnings CAGR with competitors
Aytu BioPharma (AYTU) five years earnings CAGR is 21.24%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | +369.27% |
| TLRY | Tilray Brands Inc | 57.78% | +171.96% |
| PRGO | Perrigo Company plc | 51.08% | +140.45% |
| RGC | Regencell Bioscience Holdings Ltd | 34.56% | +62.70% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | +33.60% |
| UTHR | United Therapeutics Corp | 26.00% | +22.38% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | +1.96% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | -18.62% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | -20.30% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | -44.32% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | -49.58% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | -50.88% |
| ZTS | Zoetis Inc - Class A | 8.54% | -59.82% |
| KMDA | Kamada Ltd | 6.87% | -67.66% |
| PRFX | PRF Technologies Ltd | 6.09% | -71.34% |
| AQST | Aquestive Therapeutics Inc | 5.03% | -76.34% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | -82.35% |
| CPHI | China Pharma Holdings Inc | 3.58% | -83.14% |
| BHC | Bausch Health Companies Inc | 3.48% | -83.61% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -86.19% |